Yuekang Pharmaceutical/ CNE100005XQ2 /
11/06/2024 04:46:24 | Chg. -0.36 | Volume | Bid11/06/2024 | Demandez à11/06/2024 | Haut | Bas |
---|---|---|---|---|---|---|
17.19CNY | -2.05% | 863,897 Chiffrre d'affaires: 14.82 Mio. |
17.19Bid taille: 676 | 17.20Ask la taille: 1,465 | 17.55 | 17.04 |
GlobeNewswire
04:50
Flash News: OKX Announces Participation in Launch of Lagrange Labs' First Production-Ready ZK Prover...
GlobeNewswire
04:19
President Lula to Speak at FII PRIORITY Rio de Janeiro Summit at the Copacabana Palace Wednesday
GlobeNewswire
03:00
AUTODESK ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been F...
GlobeNewswire
03:00
MARINUS ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Fi...
GlobeNewswire
02:00
ROSEN, LEADING INVESTOR COUNSEL, Encourages Teladoc Health, Inc. Investors to Secure Counsel Before ...
GlobeNewswire
02:00
ROSEN, A LONGSTANDING LAW FIRM, Encourages Marinus Pharmaceuticals, Inc. Investors to Secure Counsel...
GlobeNewswire
01:19
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Masimo Corporation Investors to Inquire About Securities...
GlobeNewswire
01:12
CoreCivic Receives Termination Notice From U.S. Immigration and Customs Enforcement At South Texas F...
GlobeNewswire
00:42
ROSEN, LEADING INVESTOR COUNSEL, Encourages Humana Inc. Investors to Secure Counsel Before Important...
GlobeNewswire
00:35
Crinetics Pharmaceuticals Announces June 2024 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
00:24
ROSEN, LEADING INVESTOR COUNSEL, Encourages Xiao-I Corporation Investors to Inquire About Securities...
- La première page
- Retour
- 1
- 2
- 3
- 4
- Suivant
- La dernière page